Chelsea Therapeutics

Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March
Minyanville
Wed, 02/29/12 - 04:52 pm
Merck
Pfizer
Bristol-Myers Squibb
Chelsea Therapeutics
Affymax
Astex
JNJ
Discovery Labs
Ariad Pharmaceuticals
NeurogesX
Amgen
Five Reasons Chelsea Therapeutics' Northera Will Get FDA Approval
TheStreet.com
Mon, 02/27/12 - 11:09 am
Chelsea Therapeutics
Northera
FDA
FDA panel recommends Chelsea Therapeutics drug
Reuters
Thu, 02/23/12 - 05:49 pm
FDA
advisory panels
Chelsea Therapeutics
Northera
Chelsea Therapeutics: FDA Panel Live Blog
TheStreet.com
Thu, 02/23/12 - 10:43 am
FDA
advisory panels
Chelsea Therapeutics
Northera
Chelsea Therapeutics Drug Shouldn’t Be Approved, FDA Says
Bloomberg Businessweek
Wed, 02/22/12 - 08:11 am
FDA
Chelsea Therapeutics
Northera
3 Biotech Takeover/LBO Potential Targets Being Snapped Up By Insiders
Seeking Alpha
Wed, 02/22/12 - 08:07 am
M&A
Seattle Genetics
Chelsea Therapeutics
Savient
Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
TheStreet.com
Fri, 02/17/12 - 09:05 am
Vivus
Chelsea Therapeutics
Keryx
Biocryst
Exelixis
BioSante
Still Betting On Chelsea's Flagship Drug?
Seeking Alpha
Wed, 02/15/12 - 10:37 am
Chelsea Therapeutics
Northera
5 High-Risk, High-Reward Biopharma Stocks
Seeking Alpha
Tue, 02/14/12 - 11:30 am
Arena Pharmaceuticals
Chelsea Therapeutics
BioLineRx
Keryx
Aeterna Zentaris
BIO CEO Conference Live Blog
TheStreet.com
Mon, 02/13/12 - 10:30 am
BIO CEO Conference
Celsion
Cyclacel
Navidea Biopharmaceuticals
Chelsea Therapeutics
Titan
Galena Biopharma
Oxigene
FDA Pharma Meetings for February
Motley Fool
Tue, 01/31/12 - 07:58 am
FDA
Amgen
Xgeva
Cell Therapeutics
Pixuvri
Vivus
Qnexa
Chelsea Therapeutics
Northera
6 Biotech Plays With High Risk/Reward Potential
Seeking Alpha
Sun, 01/22/12 - 12:20 pm
Vertex Pharmaceuticals
Chelsea Therapeutics
ONYX Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Cell Therapeutics
10 Biotech Stocks With Strong Corporate Governance
Seeking Alpha
Wed, 01/18/12 - 10:03 am
Amgen
Achillion
Chelsea Therapeutics
Charles River Laboratories
Indenix
Human Genome Sciences
Incyte
Immunogen
NPS Pharmaceuticals
PDL Biopharma
Chelsea Therapeutics fibromyalgia drug shows promise
Reuters
Thu, 12/22/11 - 08:51 am
Chelsea Therapeutics
fibromyalgia
carbidopa
Chelsea Therapeutics gets patent protection on hypotension drug
Reuters
Thu, 12/15/11 - 09:46 am
Chelsea Therapeutics
hypotension
Northera
neurogenic orthostatic hypotension
Parkinson's Disease
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
20 Biotech Stocks That Hedge Funds Are Selling
Seeking Alpha
Sun, 12/11/11 - 02:40 pm
Nabi
Pacific Biosciences
Dendreon
Momenta
Enzon
Acorda Therapeutics
ShangPharma
Charles River Laboratories
Sangamo BioSciences
BioSpecifics Technologies
Jazz Pharmaceuticals
Amgen
Sinovac Biotech
ViroPharma
Vanda
Insmed
Transcept
Cadence Pharmaceuticals
PDL Biopharma
Chelsea Therapeutics
5 High Risk/Reward Biotechs For 2012
Seeking Alpha
Mon, 12/5/11 - 06:13 pm
ONYX Pharmaceuticals
Vertex Pharmaceuticals
Amarin
Chelsea Therapeutics
Cell Therapeutics
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Biotech Takeovers Could Heat Up These Stocks
Seeking Alpha
Fri, 11/18/11 - 11:47 am
M&A
Acorda
Alnylam
Adolor
Cubist
Chelsea Therapeutics
Catalyst
Human Genome Sciences

Pages